Related Experiment Video
Updated: Jun 24, 2026

Mass Isolation and In Vitro Cultivation of Intramolluscan Stages of the Human Blood Fluke Schistosoma Mansoni
Published on: January 14, 2018
Ivermectin as Mass Drug Administration for Scabies - The Need of the Hour
Satyaki Ganguly1, Parul Verma2, P Narsimha Rao3
1Additional Professor, Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Summary:
Scabies is a highly transmissible disease caused by the mite, Sarcoptes scabiei var. hominis . Although any age group can be affected, it is common in children. Infestation by the mite usually leads to itching, which can be very disabling with effects on sleep, concentration, and other daily activities. In addition, secondary bacterial skin infections (e.g., impetigo) are common. Treatment options include 5% permethrin cream and oral ivermectin. In small community-based trials, mass drug administration of ivermectin has been shown to substantially decrease the prevalence of both scabies and secondary impetigo; however, their effect at a large scale is untested.
Insights
Scabies, a mite-caused skin disease, causes severe itching and secondary infections, especially in children. Mass ivermectin drug administration shows promise in reducing scabies and impetigo prevalence in small trials, but large-scale effectiveness remains unproven.
Area of Science:
- Dermatology
- Infectious Diseases
- Public Health
Background:
- Scabies is a highly contagious skin infestation caused by the mite Sarcoptes scabiei var. hominis.
- It commonly affects children, leading to intense itching and sleep disturbances.
- Secondary bacterial infections, such as impetigo, frequently complicate scabies infestations.
Purpose of the Study:
- To summarize the current understanding of scabies transmission, clinical impact, and treatment options.
- To review the evidence for mass drug administration of ivermectin in scabies control.
- To highlight the need for large-scale studies on ivermectin's effectiveness.
Main Methods:
- Review of existing literature on scabies epidemiology and treatment.
- Analysis of findings from community-based trials on mass drug administration of ivermectin.
- Assessment of the scalability of ivermectin treatment strategies.
Main Results:
- Scabies infestation causes significant morbidity, including disabling itch and secondary infections.
- Oral ivermectin and topical permethrin are established treatment options.
- Small-scale trials indicate mass ivermectin administration can reduce scabies and impetigo prevalence.
Conclusions:
- Scabies remains a significant public health concern, particularly in pediatric populations.
- Mass drug administration of ivermectin presents a potential strategy for community-level scabies control.
- Further large-scale research is required to validate the effectiveness and feasibility of widespread ivermectin use for scabies eradication.
Related Concept Videos
Anthelminthic Agents
Smallpox
Antiprotozoal Agents
Leishmaniasis
Hand hygiene
Hand washing...
Chemical Agents for Microbial Control